Fortress Biotech, Inc. (FBIO) vs OS Therapies Incorporated (OSTX)
- Fortress Biotech, Inc. FBIO 1.87 −2.09%
- OS Therapies Incorporated OSTX 1.32 −6.38%
Fortress Biotech, Inc. and OS Therapies Incorporated are both Biotechnology companies. Fortress Biotech, Inc. and OS Therapies Incorporated are of similar size ($66.0M and $63.7M). OS Therapies Incorporated has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.6×. Fortress Biotech, Inc. has the higher net margin (151.0% vs 0.00%) and the lower return on invested capital (−41.3% vs 0.00%). Across the 12 metrics below, Fortress Biotech, Inc. leads on 7 and OS Therapies Incorporated on 5.
Valuation
Profitability
| Metric | FBIO | OSTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 65.59% | — | 65.16% |
| Operating margin | (42.61%) | 0.00% | 0.00% |
| Net margin | 150.98% | 0.00% | 0.00% |
| Free cash flow margin | 183.80% | 0.00% | 0.00% |
| Return on equity | 84.91% | 1,129.52% | (56.36%) |
| Return on assets | 43.38% | (389.65%) | (48.04%) |
| Return on invested capital | (41.34%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack